NIPBL
Summary: This gene encodes the homolog of the Drosophila melanogaster Nipped-B gene product and fungal Scc2-type sister chromatid cohesion proteins. The Drosophila protein facilitates enhancer-promoter communication of remote enhancers and plays a role in developmental regulation. It is also homologous to a family of chromosomal adherins with broad roles in sister chromatid cohesion, chromosome condensation, and DNA repair. The human protein has a bipartite nuclear targeting sequence and a putative HEAT repeat. Condensins, cohesins and other complexes with chromosome-related functions also contain HEAT repeats. Mutations in this gene result in Cornelia de Lange syndrome, a disorder characterized by dysmorphic facial features, growth delay, limb reduction defects, and cognitive disability. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| NIPBL, cohesin loading factor | MIM:608667 | Ensembl:ENSG00000164190 | HGNC:HGNC:28862 | PA134962343 | 5p13.2 |
Gene Categories:
HISTONE MODIFICATIONGO terms in NIPBL
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| CC | IBA | GO:0000228 | nuclear chromosome |
| CC | IBA | GO:0000785 | chromatin |
| CC | IEA | GO:0000785 | chromatin |
| CC | IBA | GO:0000790 | nuclear chromatin |
| CC | IBA | GO:0005634 | nucleus |
| CC | IDA | GO:0005634 | nucleus |
| CC | TAS | GO:0005654 | nucleoplasm |
| CC | ISS | GO:0032039 | integrator complex |
| CC | IDA | GO:0032116 | SMC loading complex |
| CC | HDA | GO:0070062 | extracellular exosome |
| CC | IBA | GO:0090694 | Scc2-Scc4 cohesin loading complex |
| CC | IDA | GO:0090694 | Scc2-Scc4 cohesin loading complex |
| BP | IDA | GO:0000122 | negative regulation of transcription by RNA polymerase II |
| BP | NAS | GO:0001656 | metanephros development |
| BP | IBA | GO:0003007 | heart morphogenesis |
| BP | IMP | GO:0003007 | heart morphogenesis |
| BP | IMP | GO:0003151 | outflow tract morphogenesis |
| BP | IBA | GO:0006302 | double-strand break repair |
| BP | IEA | GO:0006351 | transcription, DNA-templated |
| BP | IMP | GO:0006974 | cellular response to DNA damage stimulus |
| BP | IBA | GO:0007064 | mitotic sister chromatid cohesion |
| BP | IMP | GO:0007064 | mitotic sister chromatid cohesion |
| BP | IBA | GO:0007076 | mitotic chromosome condensation |
| BP | IBA | GO:0007420 | brain development |
| BP | IMP | GO:0007420 | brain development |
| BP | IBA | GO:0007507 | heart development |
| BP | IMP | GO:0007605 | sensory perception of sound |
| BP | IEA | GO:0019827 | stem cell population maintenance |
| BP | IDA | GO:0031065 | positive regulation of histone deacetylation |
| BP | IBA | GO:0034087 | establishment of mitotic sister chromatid cohesion |
| BP | IMP | GO:0034088 | maintenance of mitotic sister chromatid cohesion |
| BP | IMP | GO:0034613 | cellular protein localization |
| BP | IMP | GO:0035115 | embryonic forelimb morphogenesis |
| BP | IMP | GO:0035136 | forelimb morphogenesis |
| BP | IMP | GO:0035261 | external genitalia morphogenesis |
| BP | IEA | GO:0040018 | positive regulation of multicellular organism growth |
| BP | IMP | GO:0042471 | ear morphogenesis |
| BP | IMP | GO:0042634 | regulation of hair cycle |
| BP | IEA | GO:0045444 | fat cell differentiation |
| BP | IEA | GO:0045778 | positive regulation of ossification |
| BP | IDA | GO:0045892 | negative regulation of transcription, DNA-templated |
| BP | IEA | GO:0045944 | positive regulation of transcription by RNA polymerase II |
| BP | IMP | GO:0045995 | regulation of embryonic development |
| BP | IMP | GO:0048557 | embryonic digestive tract morphogenesis |
| BP | IBA | GO:0048565 | digestive tract development |
| BP | IMP | GO:0048589 | developmental growth |
| BP | IMP | GO:0048592 | eye morphogenesis |
| BP | IMP | GO:0048638 | regulation of developmental growth |
| BP | IBA | GO:0048703 | embryonic viscerocranium morphogenesis |
| BP | IEA | GO:0048703 | embryonic viscerocranium morphogenesis |
| BP | IMP | GO:0050890 | cognition |
| BP | IMP | GO:0060325 | face morphogenesis |
| BP | IMP | GO:0061010 | gall bladder development |
| BP | IMP | GO:0061038 | uterus morphogenesis |
| BP | IBA | GO:0070550 | rDNA condensation |
| BP | IBA | GO:0071169 | establishment of protein localization to chromatin |
| BP | IMP | GO:0071481 | cellular response to X-ray |
| BP | IBA | GO:0071733 | transcriptional activation by promoter-enhancer looping |
| BP | IDA | GO:0071921 | cohesin loading |
| BP | IBA | GO:1905406 | positive regulation of mitotic cohesin loading |
| BP | IBA | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange |
| BP | ISS | GO:2001224 | positive regulation of neuron migration |
| MF | IBA | GO:0003682 | chromatin binding |
| MF | IEA | GO:0003682 | chromatin binding |
| MF | IPI | GO:0005515 | protein binding |
| MF | IPI | GO:0008022 | protein C-terminus binding |
| MF | IEA | GO:0036033 | mediator complex binding |
| MF | IPI | GO:0042826 | histone deacetylase binding |
| MF | IPI | GO:0047485 | protein N-terminus binding |
| MF | IPI | GO:0070087 | chromo shadow domain binding |
Gene expression in normal tissue: NIPBL
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in NIPBL
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-1640170 | Cell Cycle |
| reactome | R-HSA-2470946 | Cohesin Loading onto Chromatin |
| reactome | R-HSA-68884 | Mitotic Telophase/Cytokinesis |
| reactome | R-HSA-68886 | M Phase |
| reactome | R-HSA-69278 | Cell Cycle, Mitotic |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD705 | Nakiterpiosin | 2 |
| iGMDRD434 | BMS-536924 | 2 |
| iGMDRD103 | SN-38 | 3 |
| iGMDRD271 | Brefeldin A | 2 |
| iGMDRD121 | GMX1778 | 2 |
| iGMDRD158 | NSC141540 | 5 |
| iGMDRD5 | Tyrphostin AG 1478 | 3 |
| iGMDRD147 | Prima-1 | 3 |
| iGMDRD353 | PD0325901 | 1 |
| iGMDRD286 | Nsc 632839 | 2 |
| iGMDRD871 | BRD6368 | 2 |
| iGMDRD872 | BRD7137 | 4 |
| iGMDRD329 | Merck60 | 3 |
| iGMDRD366 | PI-103 | 2 |
| iGMDRD116 | CD437 | 2 |
| iGMDRD345 | Compound 10b [PMID: 11504634] | 1 |
| iGMDRD299 | ICL 670 | 2 |
| iGMDRD79 | Gemcitabine | 2 |
| iGMDRD512 | nutlin 3 | 2 |
| iGMDRD123 | Isoevodiamine | 4 |
| iGMDRD883 | CIL55A | 1 |
| iGMDRD945 | ML214 | 3 |
| iGMDRD341 | Triacsin c | 3 |
| iGMDRD85 | Ursolic acid | 1 |
| iGMDRD351 | GW843682X | 4 |
| iGMDRD698 | Neratinib | 1 |
| iGMDRD237 | ABT-751 | 2 |
| iGMDRD885 | Compound 110 | 3 |
| iGMDRD187 | BRD9876 | 3 |
| iGMDRD870 | BRD63610 | 7 |
| iGMDRD270 | Ciclosporin | 3 |
| iGMDRD255 | SB225002 | 2 |
| iGMDRD260 | FQI-2 | 6 |
| iGMDRD64 | Parbendazole | 6 |
| iGMDRD451 | Serdemetan | 1 |
| iGMDRD188 | Piperlongumine | 7 |
| iGMDRD100 | Zebularine | 2 |
| iGMDRD399 | Selumetinib | 5 |
| iGMDRD506 | Fedratinib | 7 |
| iGMDRD577 | BIX01294 | 2 |
| iGMDRD562 | Navitoclax | 8 |
| iGMDRD427 | ABT737 | 3 |
| iGMDRD779 | PRL-3 Inhibitor I | 3 |
| iGMDRD670 | ML 210 | 3 |
| iGMDRD483 | SCH-529074 | 1 |
| iGMDRD494 | Neopeltolide | 1 |
| iGMDRD462 | OSI-906 (Linsitinib) | 2 |
| iGMDRD781 | Sirolimus | 2 |
| iGMDRD126 | Tipifarnib | 5 |
| iGMDRD151 | CHM-1 | 6 |
| iGMDRD599 | Salermide | 1 |
| iGMDRD420 | Leucascandrolide A | 2 |
| iGMDRD1008 | SR-II-138A | 6 |
| iGMDRD466 | Chaetocin | 2 |
| iGMDRD280 | CYTOCHALASIN B | 1 |
| iGMDRD679 | Bistramide A | 2 |
| iGMDRD446 | LY 2183240 | 3 |
| iGMDRD193 | Fqi1 | 3 |
| iGMDRD152 | 179324-69-7 | 1 |
| iGMDRD61 | Kinetin riboside | 4 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in NIPBL

